News from NYU Langone Health
NYU Langone Acquires Palm Beach County Medical Practice. (South Florida Business Journal)
Paywalled* The South Florida Business Journal (7/2)* “NYU Langone Health, the health care system of New York University, acquired Florida Cardiology Group in Atlantis,” which will “be renamed NYU Langone Cardiology Associates – Atlantis/Lake Worth.” Andrew Rubin, senior vice president, clinical affairs and ambulatory care, said, “This is an exciting addition to our network, particularly as NYU Langone Health plans for a significant expansion of services in Florida in 2026, when we will open a new home for the Julia Koch Family Ambulatory Care Center, a state-of-the-art, eight-story facility with space for 50 physicians in West Palm Beach.”
Also reporting is Becker’s ASC Review (7/2).
NY Doctors Are Prescribing Far Fewer Opioids. Not Everyone Agrees That’s A Good Thing. (Gothamist (NY))
Gothamist (NY) (7/2) “Studies have also found that abruptly cutting off the supply of prescription opioids for patients who were dependent on them likely led some to pivot to heroin, driving another wave of overdose deaths, said Magdalena Cerda, DrPH, professor, Department of Population Health,” who added, “Had treatment been more available, that might have prevented some of these unintended consequences.”
Dementia Risk Increased In Patients On Dialysis Diagnosed With Sleep Disorders. (RheumatologyAdvisor)
RheumatologyAdvisor (7/2) “Among 216,158 patients aged 66 years and older with kidney failure in the US Renal Data System database (2008-2019), 26.3% of patients received a first-time diagnosis of a sleep disorder within 180 days of initiating dialysis, Mara A. McAdams-DeMarco, PhD, associate professor, Departments of Surgery, and Population Health, Center for Surgical and Transplant Applied Research, said, “and colleagues reported in the Clinical Journal of the American Society of Nephrology.”
What To Know About The Next Generation Of COVID-19 Vaccines. (ABC News)
ABC News (7/2) “The first phase of human trials studying a possible nasal COVID-19 vaccine has opened, the National Institutes of Health (NIH) announced,” which will “enroll 60 healthy adult participants between ages 18 and 64 who received at least three doses of an MRNA COVID-19 vaccine approved or authorized by the FDA” at a number of trial sites including NYU Grossman School of Medicine.
Liver Problems Symptoms & Causes: 11 Common Signs From Doctors. (TODAY)
TODAY (7/2) “‘Basically, anything we put in our body – medications, alcohol, supplements, everything – needs to go through the liver,’ Lisa Ganjhu, DO, clinical associate professor, Department of Medicine, Division of Gastroenterology and Hepatology, tells TODAY.com.”
Dr. Punekar On The Evaluation Of NT-112 In KRAS G12D+ Advanced Solid Tumors. (OncLive)
OncLive (7/2) Salman R. Punekar, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, “discusses the rationale and design behind an open-label, phase 1, multicenter study (NCT06218914) evaluating the safety and preliminary antitumor activity of NT-112 in patients who are human leukocyte antigen (HLA)-C*08:02 positive and have unresectable, locally advanced or metastatic solid tumors harboring KRAS G12D mutations.”
Study Suggests Regular Vaccine Boosts May Help People Who Are Immunocompromised Fight COVID-19. (ReachMD)
ReachMD (7/3) “In a study published...in the journal Clinical Infectious Diseases, a Johns Hopkins Medicine research team,” which also includes former Johns Hopkins Medicine transplant surgeon Dory L. Segev, MD, PhD, professor, Departments of Surgery, and Population Health, vice chair, Department of Surgery and Surgical Sciences, “reports that for XBB.1.5, there is good news for solid organ transplant recipients (SOTRs) and other immunocompromised people who receive regular booster doses of a messenger RNA (mRNA) bivalent vaccine (a vaccine designed to enhance immunity to a variety of SARS-CoV-2 strains).”
FDA Approves New Alzheimer’s Drug. (NBC News)
NBC News (7/3) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, reacting to the news that the FDA approved a new Alzheimer’s drug, Cassana, which modestly slows cognitive decline, explained that Cassana and Lakembi, both monoclonal antibodies, target amyloid plaques in the brain.
Summer Safety Checklist: How To Treat Injuries And Stay Safe. (TODAY)
TODAY (7/2) “From treating cuts and bruises and making your own bug bite cream, to water safety tips and more, NBC News medical contributor, Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, “joins TODAY to share medical advice to stay safe this summer.”
COVID Summer Surge? What The Latest Data Is Revealing About NY, NJ Infections. (WNYW-TV New York)
WNYW-TV New York (7/2) Purvi S. Parikh, MD, clinical assistant professor, Department of Pediatrics, Division of Pediatric Allergy & Immunology, and Department of Medicine, Division of Infectious Diseases, said, “With extreme heat and heat waves, people do spend more time indoors than they typically do in the summertime and more time indoors means increased transmission.”
Alabama Woman Bitten By Rabid Fox While Unloading Groceries From Car: ‘Public Health Threat’. (Fox News)
Fox News (7/2) “Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation and Fox News medical contributor, spoke with Fox News Digital about post-exposure prophylaxis (PEP),” saying, “Rabies treatments are reliably found in emergency rooms, as there isn’t enough demand to keep the shots in every doctor’s office or urgent care clinic.”
In a separate article, Fox News (7/2) “Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation and a Fox News medical contributor, who was not involved in the drug trials, noted that donanemab is very similar to Leqembi, the current drug on the market that blocks amyloid formation.”
Medication Overuse In Mental Health Facilities: Not The Answer, Regardless Of Consent, Says Ethicist. (MDEdge)
MDEdge (7/2) Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, discusses recent studies that show “that certain medications that basically are used to, if you will, quiet patients – antipsychotic drugs – are being overused, particularly in facilities that serve poorer people and people who are minorities,” a situation he calls “utterly, ethically unacceptable.”
News From NYU Langone Hospital – Brooklyn
Why Your Body Gets Hot at Night. (Health Central)
Health Central (7/2) “While the majority of women who experience hot flashes do so during perimenopause, other hormonal fluctuations could also affect the body’s temperature control system and lead to night sweats, according to Meleen Chuang, MD, clinical associate professor, Department of Obstetrics and Gynecology, chief, Obstetrics and Gynecology, Family Health Centers, NYU Langone Hospital—Brooklyn, in New York City.”
